AR and breast cancer: For example, several studies indicated that the Notch pathway and immunomodulatory, inflammatory and mitogenic­activated pathways are signatures of breast cancer CTCs associated with brain metastasis38, but activated androgen receptor (AR) signaling provides a signature of breast CTCs associated with bone metastasis37.